Abstract
We compared the oestrogenic and anti-oestrogenic properties of the two well-known phyto-oestrogens, genistein and quercetin, on the oestrogen-sensitive breast cancer cell line MCF-7. Genistein exerted a biphasic effect on growth of MCF-7 cells, stimulating at low and inhibiting at high concentrations, whereas quercetin was only growth inhibitory. At doses which did not inhibit cell growth, respectively 5 and 1 μM, genistein and quercetin counteracted oestrogen- and transforming growth factor-α-promoted cell growth stimulation. Furthermore, genistein promoted transcription of the oestrogen-regulated genes pS2 and cathepsin-D, whereas quercetin interfered with the oestrogen-induced expression of the proteins. In in vitro binding experiments, genistein competed with oestradiol for binding to the oestrogen receptor (ER), but quercetin did not. Quercetin and genistein down-regulated cytoplasmic ER levels and promoted a tighter nuclear association of the ER, but only genistein was able to up-regulate progesterone receptor protein levels. In gel mobility assays, ER preincubation with oestradiol or with the two phyto-oestrogens led to the appearance of the same retarded band, excluding differences between the various complexes in binding to the consensus sequence. The data allowed us to conclude that quercetin acts like a pure anti-oestrogen, whereas genistein displays mixed agonist/antagonist properties, and to formulate a hypothesis on the possible mechanism of action of such phyto-oestrogens. © 1999 Cancer Research Campaign
Keywords: genistein, quercetin, oestrogen receptor, breast cancer, phyto-oestrogens
Full Text
The Full Text of this article is available as a PDF (144.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adlercreutz C. H., Goldin B. R., Gorbach S. L., Höckerstedt K. A., Watanabe S., Hämäläinen E. K., Markkanen M. H., Mäkelä T. H., Wähälä K. T., Adlercreutz T. Soybean phytoestrogen intake and cancer risk. J Nutr. 1995 Mar;125(3 Suppl):757S–770S. doi: 10.1093/jn/125.3_Suppl.757S. [DOI] [PubMed] [Google Scholar]
- Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest Suppl. 1990;201:3–23. [PubMed] [Google Scholar]
- Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987 Apr 25;262(12):5592–5595. [PubMed] [Google Scholar]
- BURTON K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J. 1956 Feb;62(2):315–323. doi: 10.1042/bj0620315. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr. 1995 Mar;125(3 Suppl):777S–783S. doi: 10.1093/jn/125.3_Suppl.777S. [DOI] [PubMed] [Google Scholar]
- Barnes S., Grubbs C., Setchell K. D., Carlson J. Soybeans inhibit mammary tumors in models of breast cancer. Prog Clin Biol Res. 1990;347:239–253. [PubMed] [Google Scholar]
- Brown M., Sharp P. A. Human estrogen receptor forms multiple protein-DNA complexes. J Biol Chem. 1990 Jul 5;265(19):11238–11243. [PubMed] [Google Scholar]
- Cappelletti V., Brivio M., Miodini P., Granata G., Coradini D., Di Fronzo G. Simultaneous estimation of epidermal growth factor receptors and steroid receptors in a series of 136 resectable primary breast tumors. Tumour Biol. 1988;9(4):200–211. doi: 10.1159/000217563. [DOI] [PubMed] [Google Scholar]
- Cappelletti V., Miodini P., Fioravanti L., Di Fronzo G. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines. Anticancer Res. 1995 Nov-Dec;15(6B):2551–2555. [PubMed] [Google Scholar]
- Cappelletti V., Ruedl C., Miodini P., Fioravanti L., Coradini D., Di Fronzo G., Silvestrini R. Paracrine interaction in co-culture of hormone-dependent and independent breast cancer cells. Breast Cancer Res Treat. 1993;26(3):275–281. doi: 10.1007/BF00665805. [DOI] [PubMed] [Google Scholar]
- Dickson R. B., Bates S. E., McManaway M. E., Lippman M. E. Characterization of estrogen responsive transforming activity in human breast cancer cell lines. Cancer Res. 1986 Apr;46(4 Pt 1):1707–1713. [PubMed] [Google Scholar]
- Fioravanti L., Cappelletti V., Miodini P., Ronchi E., Brivio M., Di Fronzo G. Genistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro. Cancer Lett. 1998 Aug 14;130(1-2):143–152. doi: 10.1016/s0304-3835(98)00130-x. [DOI] [PubMed] [Google Scholar]
- Horwitz K. B., Jackson T. A., Bain D. L., Richer J. K., Takimoto G. S., Tung L. Nuclear receptor coactivators and corepressors. Mol Endocrinol. 1996 Oct;10(10):1167–1177. doi: 10.1210/mend.10.10.9121485. [DOI] [PubMed] [Google Scholar]
- Katzenellenbogen J. A., O'Malley B. W., Katzenellenbogen B. S. Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol Endocrinol. 1996 Feb;10(2):119–131. doi: 10.1210/mend.10.2.8825552. [DOI] [PubMed] [Google Scholar]
- Kuo S. M. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett. 1996 Dec 20;110(1-2):41–48. doi: 10.1016/s0304-3835(96)04458-8. [DOI] [PubMed] [Google Scholar]
- Kühnau J. The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet. 1976;24:117–191. [PubMed] [Google Scholar]
- Lamartiniere C. A., Moore J. B., Brown N. M., Thompson R., Hardin M. J., Barnes S. Genistein suppresses mammary cancer in rats. Carcinogenesis. 1995 Nov;16(11):2833–2840. doi: 10.1093/carcin/16.11.2833. [DOI] [PubMed] [Google Scholar]
- Larocca L. M., Piantelli M., Leone G., Sica S., Teofili L., Panici P. B., Scambia G., Mancuso S., Capelli A., Ranelletti F. O. Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoids. Br J Haematol. 1990 Aug;75(4):489–495. doi: 10.1111/j.1365-2141.1990.tb07787.x. [DOI] [PubMed] [Google Scholar]
- Lock M. Contested meanings of the menopause. Lancet. 1991 May 25;337(8752):1270–1272. doi: 10.1016/0140-6736(91)92931-q. [DOI] [PubMed] [Google Scholar]
- Markovits J., Linassier C., Fossé P., Couprie J., Pierre J., Jacquemin-Sablon A., Saucier J. M., Le Pecq J. B., Larsen A. K. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res. 1989 Sep 15;49(18):5111–5117. [PubMed] [Google Scholar]
- Martin P. M., Horwitz K. B., Ryan D. S., McGuire W. L. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology. 1978 Nov;103(5):1860–1867. doi: 10.1210/endo-103-5-1860. [DOI] [PubMed] [Google Scholar]
- Ronchi E., Granata G., Brivio M., Coradini D., Miodini P., Di Fronzo G. A double-labeling assay for simultaneous estimation and characterization of estrogen and progesterone receptors using radioiodinated estradiol and tritiated Org 2058. Tumori. 1986 Jun 30;72(3):251–257. doi: 10.1177/030089168607200305. [DOI] [PubMed] [Google Scholar]
- Ross P. D., Norimatsu H., Davis J. W., Yano K., Wasnich R. D., Fujiwara S., Hosoda Y., Melton L. J., 3rd A comparison of hip fracture incidence among native Japanese, Japanese Americans, and American Caucasians. Am J Epidemiol. 1991 Apr 15;133(8):801–809. doi: 10.1093/oxfordjournals.aje.a115959. [DOI] [PubMed] [Google Scholar]
- Scambia G., Ranelletti F. O., Panici P. B., Piantelli M., Bonanno G., De Vincenzo R., Ferrandina G., Rumi C., Larocca L. M., Mancuso S. Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells. Br J Cancer. 1990 Dec;62(6):942–946. doi: 10.1038/bjc.1990.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scambia G., Ranelletti F. O., Panici P. B., Piantelli M., De Vincenzo R., Ferrandina G., Bonanno G., Capelli A., Mancuso S. Quercetin induces type-II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell lines. Int J Cancer. 1993 May 28;54(3):462–466. doi: 10.1002/ijc.2910540318. [DOI] [PubMed] [Google Scholar]
- Singhal R. L., Yeh Y. A., Praja N., Olah E., Sledge G. W., Jr, Weber G. Quercetin down-regulates signal transduction in human breast carcinoma cells. Biochem Biophys Res Commun. 1995 Mar 8;208(1):425–431. doi: 10.1006/bbrc.1995.1355. [DOI] [PubMed] [Google Scholar]
- Soto A. M., Sonnenschein C. The role of estrogens on the proliferation of human breast tumor cells (MCF-7). J Steroid Biochem. 1985 Jul;23(1):87–94. doi: 10.1016/0022-4731(85)90265-1. [DOI] [PubMed] [Google Scholar]
- Yanagihara K., Ito A., Toge T., Numoto M. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res. 1993 Dec 1;53(23):5815–5821. [PubMed] [Google Scholar]
- Zava D. T., Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer. 1997;27(1):31–40. doi: 10.1080/01635589709514498. [DOI] [PubMed] [Google Scholar]